ErbB Receptors in the Biology and Pathology of the Aerodigestive Tract

Por Morgan, Sarah, Grandis, Jennifer R.
Publicado em 2008

Investigational EGFR-targeted therapies in HNSCC

Por Cassell, Andre, Grandis, Jennifer R.
Publicado em 2010

New advances in molecular approaches to head and neck squamous cell carcinoma

Por Sahu, Nivedita, Grandis, Jennifer R.
Publicado em 2011

Emerging drugs to treat squamous cell carcinomas of the head and neck

Por Fung, Christopher, Grandis, Jennifer R
Publicado em 2010

Nucleic acid-based approaches to STAT inhibition

Por Sen, Malabika, Grandis, Jennifer R.
Publicado em 2012

Receptor-type protein tyrosine phosphatases in cancer

Por Du, Yu, Grandis, Jennifer R.
Publicado no Chin J Cancer (2015)

Emerging drugs for head and neck cancer

Por Wen, Yihui, Grandis, Jennifer R
Publicado no Expert Opin Emerg Drugs (2015)

Targeting EGFR and Src Pathways in Head and Neck Cancer

Por Egloff, Ann Marie, Grandis, Jennifer R.
Publicado em 2008

STAT3 SIGNALING: Anticancer Strategies and Challenges

Por Johnston, Paul A., Grandis, Jennifer R.
Publicado em 2011

The molecular pathogenesis of head and neck cancer

Por Klein, Jonah D., Grandis, Jennifer R.
Publicado em 2010

Response to Combined Molecular Targeting: Defining the Role of P-STAT3

Por Egloff, Ann Marie, Grandis, Jennifer R.
Publicado em 2011

Molecular Pathways: Context-dependent approaches to Notch targeting as cancer therapy

Por Egloff, Ann Marie, Grandis, Jennifer R.
Publicado em 2012

Dual kinase inhibition of EGFR and HER2 overcomes resistance to cetuximab in a novel in vivo model of acquired cetuximab resistance

Por Quesnelle, Kelly M., Grandis, Jennifer R.
Publicado em 2011

Critical analysis of the potential for targeting STAT3 in human malignancy

Por Peyser, Noah D, Grandis, Jennifer R
Publicado em 2013

Cisplatin-Based Chemotherapy Options for Recurrent and/or Metastatic Squamous Cell Cancer of the Head and Neck

Por Pendleton, Kelsey P., Grandis, Jennifer R.
Publicado em 2013

Targeting secondary immune responses to cetuximab: CD137 and the outside story

Por Bauman, Julie E., Grandis, Jennifer R.
Publicado em 2014

HER2 as a Therapeutic Target in Head and Neck Squamous Cell Carcinoma

Por Pollock, Netanya I., Grandis, Jennifer R.
Publicado no Clin Cancer Res (2014)

Female hormonal and reproductive factors and head and neck squamous cell carcinoma risk

Por Langevin, Scott M., Grandis, Jennifer R., Taioli, Emanuela
Publicado em 2011

Therapeutic insights from genomic studies of head and neck squamous cell carcinomas

Por Hammerman, Peter S., Hayes, D. Neil, Grandis, Jennifer R.
Publicado no Cancer Discov (2015)

New Therapies in Head and Neck Cancer

Por Santuray, Rodell T., Johnson, Daniel E., Grandis, Jennifer R.
Publicado no Trends Cancer (2018)